COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,802 Articles (22,527 medRxiv, 8,275 bioRxiv)

Most recent first Previous |  Page 1896: Articles 18951-18960  | Next

Genomic diversity of SARS-CoV-2 can be accelerated by a mutation in the nsp14 gene
Takada, K., Ueda, M. T., Watanabe, T., Nakagawa, S.
10.1101/2020.12.23.424231 — Posted: 2020-12-26
TCR meta-clonotypes for biomarker discovery with tcrdist3: quantification of public, HLA-restricted TCR biomarkers of SARS-CoV-2 infection
Mayer-Blackwell, K., Schattgen, S., Cohen-Lavi, L., Crawford, J. C., Souquette, A., Gaevert, J. A., Hertz, T., Thomas, P. G., Bradley, P. H., Fiore-Gartland, A.
10.1101/2020.12.24.424260 — Posted: 2020-12-26
Influence of HLA class II polymorphism on predicted cellular immunity against SARS-CoV-2 at the population and individual level
Copley, H. C., Gragert, L., Leach, A. R., Kosmoliaptsis, V.
10.1101/2020.12.24.424326 — Posted: 2020-12-26
Differential Dynamic Behavior of Prefusion Spike Proteins of SARS Coronaviruses 1 and 2
Govind Kumar, V., Ogden, D. S., Isu, U., Polasa, A., Losey, J., Moradi, M.
10.1101/2020.12.25.424008 — Posted: 2020-12-26
Genetic epidemiology of variants associated with immune escape from global SARS-CoV-2 genomes
Jolly, B., Rophina, M., Shamnath, A., Imran, M., Bhoyar, R. C., Divakar, M. K., Rani, P. R., Ranjan, G., Sehgal, P., Chandrasekhar, P., Afsar, S., Lakshmi, J. V., Surekha, A., Sivasubbu, S., Scaria, V.
10.1101/2020.12.24.424332 — Posted: 2020-12-26
Support and follow-up needs of patients discharged from Intensive Care after severe COVID-19: a mixed-methods study of the views of UK general practitioners and intensive care staff during the pandemic's first wave
Castro-Avila, A. C., Jefferson, L., Dale, V., Bloor, K.
10.1101/2020.12.23.20248798 — Posted: 2020-12-26
Characteristic spatial scales of SARS-CoV-2 pandemics: lessons from mass rapid antigen testing in Slovakia
Bodova, K., Kollar, R.
10.1101/2020.12.23.20248808 — Posted: 2020-12-26
Prognostic and predictive biomarkers in patients with COVID-19 treated with tocilizumab in a randomised controlled trial
Tom, J., Bao, M., Tsai, L., Qamra, A., Summers, D., Carrasco-Triguero, M., McBride, J., Rosenberger, C. M., Lin, C. J. F., Stubbings, W., Blyth, K. G., Carratala, J., Francois, B., Benfield, T., Haslem, D., Bonfanti, P., van der Leest, C. H., Rohatgi, N., Wiese, L., Luyt, C. E., Kheradmand, F., Rosas, I. O., Cai, F.
10.1101/2020.12.23.20247379 — Posted: 2020-12-26
The importance of continued non-pharmaceutical interventions during the upcoming SARS-COV-2 vaccination campaign
Galanti, M., Pei, S., Yamana, T. K., Angulo, F. J., Charos, A., Swerdlow, D. L., Shaman, J.
10.1101/2020.12.23.20248784 — Posted: 2020-12-26
Association between Use of Qingfei Paidu Tang and Mortality in Hospitalized Patients with COVID-19: A national retrospective registry study
Zhang, L., Zheng, X., Bai, X., Wang, Q., Chen, B., Wang, H., Lu, J., Hu, S., Zhang, X., Zhang, H., Liu, J., Shi, Y., Zhou, Z., Gan, L., Li, X., Li, J.
10.1101/2020.12.23.20248444 — Posted: 2020-12-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).